Literature DB >> 15814249

Preparation and characterization of poly-epsilon-caprolactone nanoparticles containing griseofulvin.

Zohra Zili1, Souad Sfar, Hatem Fessi.   

Abstract

Griseofulvin is an antifungal agent with poor solubility and low bioavailability. The aim of this work was to prepare poly-epsilon-caprolactone nanospheres and nanocapsules of griseofulvin by nanoprecipitation and to characterize them. Nanoparticles of griseofulvin were obtained with high encapsulation efficiency. The particle size was about 250-326 nm for nanospheres and 390-400 nm for nanocapsules. The dissolution rate of griseofulvin nanoparticles was higher than that of micronized griseofulvin therefore recourse to nanoencapsulation of griseofulvin should enhance its bioavailability and possibly its efficiency for the treatment of dermatomycosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15814249     DOI: 10.1016/j.ijpharm.2005.01.020

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  14 in total

1.  Investigation of the milling-induced thermal behavior of crystalline and amorphous griseofulvin.

Authors:  Niraj S Trasi; Stephan X M Boerrigter; Stephen Robert Byrn
Journal:  Pharm Res       Date:  2010-05-18       Impact factor: 4.200

2.  Mechanically induced amorphization of drugs: a study of the thermal behavior of cryomilled compounds.

Authors:  Niraj S Trasi; Stephen R Byrn
Journal:  AAPS PharmSciTech       Date:  2012-05-15       Impact factor: 3.246

3.  Naringenin-loaded nanoparticles improve the physicochemical properties and the hepatoprotective effects of naringenin in orally-administered rats with CCl(4)-induced acute liver failure.

Authors:  Feng-Lin Yen; Tzu-Hui Wu; Liang-Tzung Lin; Thau-Ming Cham; Chun-Ching Lin
Journal:  Pharm Res       Date:  2008-11-25       Impact factor: 4.200

4.  L-tyrosine-loaded nanoparticles increase the antitumoral activity of direct electric current in a metastatic melanoma cell model.

Authors:  Vânia Emerich Bucco de Campos; Cesar Augusto Antunes Teixeira; Venicio Feo da Veiga; Eduardo Ricci; Carla Holandino
Journal:  Int J Nanomedicine       Date:  2010-11-15

5.  Nanostructured delivery system for zinc phthalocyanine: preparation, characterization, and phototoxicity study against human lung adenocarcinoma A549 cells.

Authors:  Mariana da Volta Soares; Mainara Rangel Oliveira; Elisabete Pereira dos Santos; Lycia de Brito Gitirana; Gleyce Moreno Barbosa; Carla Holandino Quaresma; Eduardo Ricci-Júnior
Journal:  Int J Nanomedicine       Date:  2011-01-25

6.  Sustained-release progesterone nanosuspension following intramuscular injection in ovariectomized rats.

Authors:  Heba F Salem
Journal:  Int J Nanomedicine       Date:  2010-11-10

7.  Eudragit nanoparticles containing genistein: formulation, development, and bioavailability assessment.

Authors:  Jingling Tang; Na Xu; Hongyu Ji; Hongmei Liu; Zhiyong Wang; Linhua Wu
Journal:  Int J Nanomedicine       Date:  2011-10-19

8.  PLGA biodegradable nanoparticles containing perphenazine or chlorpromazine hydrochloride: effect of formulation and release.

Authors:  Mohammed Halayqa; Urszula Domańska
Journal:  Int J Mol Sci       Date:  2014-12-22       Impact factor: 5.923

9.  Toxicity nanoinsecticide based on clove essential oil against Tribolium castaneum (Herbst).

Authors:  Silvi Ikawati; Toto Himawan; Abdul Latief Abadi; Hagus Tarno
Journal:  J Pestic Sci       Date:  2021-05-20       Impact factor: 2.529

10.  Polymeric Nanoparticles of Brazilian Red Propolis Extract: Preparation, Characterization, Antioxidant and Leishmanicidal Activity.

Authors:  Ticiano Gomes do Nascimento; Priscilla Fonseca da Silva; Lais Farias Azevedo; Louisianny Guerra da Rocha; Isabel Cristina Celerino de Moraes Porto; Túlio Flávio Accioly Lima E Moura; Irinaldo Diniz Basílio-Júnior; Luciano Aparecido Meireles Grillo; Camila Braga Dornelas; Eduardo Jorge da Silva Fonseca; Eduardo de Jesus Oliveira; Alex Tong Zhang; David G Watson
Journal:  Nanoscale Res Lett       Date:  2016-06-17       Impact factor: 4.703

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.